美好医疗
(301363)
| 流通市值：37.72亿 | | | 总市值：137.33亿 |
| 流通股本：1.56亿 | | | 总股本：5.69亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 732,816,682.76 | 295,757,022.22 | 1,594,208,109.7 | 1,156,571,221.99 |
| 营业收入 | 732,816,682.76 | 295,757,022.22 | 1,594,208,109.7 | 1,156,571,221.99 |
| 二、营业总成本 | 599,878,465.56 | 246,494,069.6 | 1,183,768,717.99 | 878,898,846.47 |
| 营业成本 | 457,872,335.92 | 179,578,329.48 | 923,398,502.6 | 673,298,597.6 |
| 税金及附加 | 7,669,951.22 | 3,928,808.21 | 15,827,532.65 | 10,661,892.44 |
| 销售费用 | 24,710,455.41 | 12,011,007.5 | 45,127,500.29 | 30,315,989.59 |
| 管理费用 | 62,364,370.52 | 31,278,719.84 | 107,766,951.8 | 74,753,349.52 |
| 研发费用 | 69,195,515.56 | 32,674,593.72 | 140,575,368.64 | 103,341,218.61 |
| 财务费用 | -21,934,163.07 | -12,977,389.15 | -48,927,137.99 | -13,472,201.29 |
| 其中:利息费用 | 37,985.51 | - | - | - |
| 其中:利息收入 | 21,227,569.51 | 9,639,020.76 | 42,677,719.14 | 30,727,362.44 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -407,103.51 | 717,117.01 | 837,654.74 | 304,900.26 |
| 加:投资收益 | 3,952,281.16 | 1,560,436.03 | 10,052,933.69 | 6,526,682.47 |
| 资产处置收益 | 28,368.05 | 15.58 | -279,865.63 | -280,245.31 |
| 资产减值损失(新) | -9,252,079.44 | -1,298,329.15 | -13,816,908.61 | -2,782,594.76 |
| 信用减值损失(新) | -1,925,030.34 | 4,540,302.77 | -7,462,009.88 | -1,802,546.35 |
| 其他收益 | 2,740,712.25 | 1,931,018.09 | 10,711,233.32 | 9,682,528.7 |
| 四、营业利润 | 128,075,365.37 | 56,713,512.95 | 410,482,429.34 | 289,321,100.53 |
| 加:营业外收入 | 114,338.76 | 112,715.3 | 5,567.56 | 4,265.56 |
| 减:营业外支出 | 78,298.81 | 6,799.04 | 235,889.44 | 99,501.41 |
| 五、利润总额 | 128,111,405.32 | 56,819,429.21 | 410,252,107.46 | 289,225,864.68 |
| 减:所得税费用 | 13,809,262.87 | 4,944,435.59 | 46,475,630.04 | 31,376,652.86 |
| 六、净利润 | 114,302,142.45 | 51,874,993.62 | 363,776,477.42 | 257,849,211.82 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 114,302,142.45 | 51,874,993.62 | 363,776,477.42 | 257,849,211.82 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 114,302,142.45 | 51,874,993.62 | 363,776,477.42 | 257,849,211.82 |
| 扣除非经常损益后的净利润 | 110,637,199.81 | 49,215,277.86 | 350,302,224.41 | 247,514,202.74 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.2 | 0.13 | 0.9 | 0.64 |
| (二)稀释每股收益 | 0.2 | 0.13 | 0.9 | 0.64 |
| 八、其他综合收益 | 25,921,615.41 | -1,581,975.66 | 21,402,594.46 | 38,949,424.1 |
| 归属于母公司股东的其他综合收益 | 25,921,615.41 | -1,581,975.66 | 21,402,594.46 | 38,949,424.1 |
| 九、综合收益总额 | 140,223,757.86 | 50,293,017.96 | 385,179,071.88 | 296,798,635.92 |
| 归属于母公司股东的综合收益总额 | 140,223,757.86 | 50,293,017.96 | 385,179,071.88 | 296,798,635.92 |
| 公告日期 | 2025-08-19 | 2025-04-25 | 2025-04-18 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |